4basebio PLC (AIM:4BB)

4basebio Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	14.05	17.8	34.6	3.07	4.35	9.59
Short-Term Investments	-	0.24	0.23	0.24	0.24	0.23
Cash & Short-Term Investments	14.05	18.04	34.83	3.31	4.59	9.81
Cash Growth	-46.19%	-48.19%	953.83%	-28.01%	-53.22%	-35.52%
Accounts Receivable	0.85	0.29	0.28	0.11	0.05	0.05
Other Receivables	-	1.21	1.07	1.07	0.97	0.56
Receivables	0.85	1.5	1.35	1.18	1.02	0.6
Inventory	0.78	0.66	0.37	0.33	0.13	0.16
Other Current Assets	1.57	0.46	0.34	0.21	0.15	0.07
Total Current Assets	17.24	20.66	36.89	5.02	5.9	10.64
Property, Plant & Equipment	4.66	4.03	4.33	4.2	3.63	2.76
Other Intangible Assets	2.89	2.56	1.08	0.59	0.45	0.17
Long-Term Deferred Charges	2.08	2.26	2.4	2.08	1.67	1.1
Other Long-Term Assets	0.24	0.03	0.03	0.03	0.04	0.03
Total Assets	27.12	29.55	44.73	11.92	11.69	14.7

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.69	1.05	1.69	0.69	0.49	0.35
Accrued Expenses	-	1.61	1.38	1.19	0.61	0.74
Current Portion of Long-Term Debt	0.04	0.04	0.15	0.26	0.32	0.36
Current Portion of Leases	0.11	0.13	0.04	0.13	0.09	0.08
Other Current Liabilities	2.05	-	-	-	-	-
Total Current Liabilities	2.88	2.83	3.27	2.28	1.52	1.52
Long-Term Debt	22.32	15.86	14.29	9.3	2.41	0.86
Long-Term Leases	0.65	0.69	0.73	0.76	0.52	0.47
Long-Term Unearned Revenue	-	0.06	0.05	0.07	0.12	0.16
Total Liabilities	25.85	19.44	18.35	12.41	4.57	3.01

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	13.8	13.8	13.77	11.13	11.13	11.13
Additional Paid-In Capital	37.25	37.25	37.25	0.71	0.71	0.71
Retained Earnings	-64.55	-55.63	-38.72	-26.39	-18.73	-13.58
Comprehensive Income & Other	14.77	14.68	14.08	14.06	14.01	13.43
Shareholders' Equity	1.27	10.11	26.38	-0.49	7.12	11.7
Total Liabilities & Equity	27.12	29.55	44.73	11.92	11.69	14.7

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	23.11	16.72	15.22	10.46	3.35	1.76
Net Cash (Debt)	-9.06	1.32	19.61	-7.15	1.24	8.06
Net Cash Growth	-	-93.26%	-	-	-84.59%	-40.34%
Net Cash Per Share	-0.58	0.09	1.50	-0.58	0.10	0.65
Filing Date Shares Outstanding	15.54	15.54	15.48	12.32	12.32	12.32
Total Common Shares Outstanding	15.54	15.54	15.48	12.32	12.32	12.32
Working Capital	14.36	17.84	33.62	2.75	4.38	9.12
Book Value Per Share	0.08	0.65	1.70	-0.04	0.58	0.95
Tangible Book Value	-1.62	7.55	25.3	-1.08	6.67	11.53
Tangible Book Value Per Share	-0.10	0.49	1.63	-0.09	0.54	0.94
Land	-	1.04	1.04	1.04	1.04	1
Machinery	-	5.08	4.58	3.67	2.8	0.88
Construction In Progress	-	-	-	-	-	0.75

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 4, 2026

Data Sources Report a data error